Insmed Incorporated (INSM) Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2009
11/6/2009 10:28:11 AM
More...
|
Insmed Incorporated (INSM) To Host Third Quarter 2009 Conference Call
10/22/2009 11:04:37 AM
More...
|
Insmed Incorporated (INSM) to Host Second Quarter 2009 Conference Call
7/31/2009 9:16:18 AM
More...
|
Insmed Incorporated (INSM) Stops Supplying Iplex To New Patients
7/27/2009 8:03:48 AM
More...
|
Insmed Incorporated (INSM) Announces Addition to the Russell 3000(R) Index
6/30/2009 12:21:30 PM
More...
|
Insmed Incorporated (INSM) Drug, Iplex Fails in Genetic Disorder Study, Shares Tank
6/25/2009 6:23:52 AM
More...
|
Insmed Incorporated (INSM) CEO Resigns Due to Health Concerns
6/16/2009 7:46:25 AM
More...
|
Insmed Incorporated (INSM) Announces First Quarter 2009 Financial Results
5/14/2009 8:14:13 AM
More...
|
Insmed Incorporated (INSM) Completes Sale of Follow-On Biologics Platform to Merck & Co., Inc. (MRK) for Gross Proceeds of $130 Million
3/31/2009 11:30:14 PM
More...
|
Insmed Incorporated (INSM) Announces Agreement With IDIS to Manage Expanded Access Programs for IPLEX(TM)
3/30/2009 10:03:08 PM
More...
|
|